(Q33669693)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381965%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

review article

1 reference

title

Mefloquine for malaria chemoprophylaxis 1992-1998: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381965%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

0 references

1 reference

Patricia Schlagenhauf

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381965%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

Schlagenhauf P

series ordinal

1

1 reference

28 July 2017

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381965%20AND%20SRC:MED&resulttype=core&format=json

Journal of Travel Medicine

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381965%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381965%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

122-133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381965%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381965%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

High prevalence of antibodies against circumsporozoite antigen of Plasmodium falciparum without development of symptomatic malaria in travelers returning from sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Food increases the bioavailability of mefloquine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Steady state pharmacokinetics of mefloquine in long-term travellers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Lack of bioequivalence of a generic mefloquine tablet with the standard product

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Effects of mefloquine alone and with alcohol on psychomotor and driving performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Long-term malaria prophylaxis with weekly mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Prevention and morbidity of malaria in non-immune subjects; a case-control study among Italian troops in Somalia and Mozambique, 1992-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Mefloquine or doxycycline prophylaxis in US troops in Somalia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Malaria among United States troops in Somalia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Malaria anticircumsporozoite antibodies in Dutch soldiers returning from sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Effectiveness of chemoprophylaxis and other determinants of malaria in travellers to Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Failure of mefloquine chemoprophylaxis for malaria in Somalia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Failure of Mefloquine Chemoprophylaxis for Malaria in Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Delay in onset of malaria with mefloquine prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Mefloquine resistance in Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Impact of UK malaria prophylaxis policy on imported malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Why is it that antimalarial drug treatments do not always work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Reversal of mefloquine resistance with penfluridol in isolates of Plasmodium falciparum from south-west Nigeria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Malaria prophylaxis. Toxicity of mefloquine is similar to that of other chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

User Acceptability Patterns for Mefloquine and Doxycycline Malaria Chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Neuropsychiatric reactions with mefloquine chemoprophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Mefloquine to prevent malaria: a systematic review of trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Mefloquine to prevent malaria. Interpretation of study was not based on evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

CNS adverse events associated with antimalarial agents. Fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Malaria Prophylaxis in Different Age Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Malaria prophylaxis. Psychological problems after mefloquine and chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Mefloquine-induced psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Encephalopathy and memory disorders during treatments with mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Mefloquine-induced grand mal seizure during malaria chemoprophylaxis in a non-epileptic subject

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Paresthesias and mefloquine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Cutaneous vasculitis associated with mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Exfoliative dermatitis during malarial prophylaxis with mefloquine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Fatal toxic epidermal necrolysis associated with mefloquine antimalarial prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Aplastic anemia during malarial prophylaxis with mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Mefloquine Prophylaxis and Hearing, Postural Control, and Vestibular Functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Tolerability and Effectiveness of Malaria Chemoprophylaxis with Mefloquine or Chloroquine with or without Co-medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X

Mefloquine prophylaxis against malaria for female travellers of childbearing age

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00843.X